LA JOLLA, Calif.--(BUSINESS WIRE)--Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today appointed Neil Gibson, Ph.D., as its chief scientific officer.
LA JOLLA, Calif.--(BUSINESS WIRE)--Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today appointed Neil Gibson, Ph.D., as its chief scientific officer.
